MHRA Approves YORVIPATH In Great Britain For Adults With Chronic Hypoparathyroidism
MHRA批准在英国为患有慢性甲状旁腺功能减退的成年人提供YORVIPATH
MHRA Approves YORVIPATH In Great Britain For Adults With Chronic Hypoparathyroidism
MHRA批准在英国为患有慢性甲状旁腺功能减退的成年人提供YORVIPATH
使用浏览器的分享功能,分享给你的好友吧